ADIPOQ and type 2 diabetes mellitus: The fact that adiponectin levels are reduced in obese individuals combined with observations that elevated levels provide protection towards development of type-2 diabetes in normal-weight individuals [24] emphasises the importance of understanding mechanisms controlling release of this adipokine.